These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33783495)
1. SEARCH Human Immunodeficiency Virus (HIV) Streamlined Treatment Intervention Reduces Mortality at a Population Level in Men With Low CD4 Counts. Kamya MR; Petersen ML; Kabami J; Ayieko J; Kwariisima D; Sang N; Clark TD; Schwab J; Charlebois ED; Cohen CR; Bukusi EA; Peng J; Jain V; Chen YH; Chamie G; Balzer LB; Havlir DV Clin Infect Dis; 2021 Oct; 73(7):e1938-e1945. PubMed ID: 33783495 [TBL] [Abstract][Full Text] [Related]
2. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya. Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596 [TBL] [Abstract][Full Text] [Related]
3. Improved Viral Suppression With Streamlined Care in the SEARCH Study. Hickey MD; Ayieko J; Kwarisiima D; Opel FJ; Owaraganise A; Balzer LB; Chamie G; Jain V; Peng J; Camlin C; Charlebois ED; Cohen CR; Bukusi EA; Kamya MR; Petersen ML; Havlir DV J Acquir Immune Defic Syndr; 2020 Dec; 85(5):571-578. PubMed ID: 32991337 [TBL] [Abstract][Full Text] [Related]
4. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda. Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823 [TBL] [Abstract][Full Text] [Related]
5. High CD4 counts associated with better economic outcomes for HIV-positive adults and their HIV-negative household members in the SEARCH Trial. Jakubowski A; Snyman K; Kwarisiima D; Sang N; Burger R; Balzer L; Clark T; Chamie G; Shade S; Cohen C; Bukusi E; Charlebois E; Kamya M; Petersen M; Havlir D; Thirumurthy H PLoS One; 2018; 13(6):e0198912. PubMed ID: 29944678 [TBL] [Abstract][Full Text] [Related]
6. Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda. Hickey MD; Ayieko J; Owaraganise A; Sim N; Balzer LB; Kabami J; Atukunda M; Opel FJ; Wafula E; Nyabuti M; Brown L; Chamie G; Jain V; Peng J; Kwarisiima D; Camlin CS; Charlebois ED; Cohen CR; Bukusi EA; Kamya MR; Petersen ML; Havlir DV PLoS Med; 2021 Sep; 18(9):e1003803. PubMed ID: 34543267 [TBL] [Abstract][Full Text] [Related]
7. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda. Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Sturt AS; Dokubo EK; Sint TT Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370 [TBL] [Abstract][Full Text] [Related]
9. Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda. Barnabas RV; van Rooyen H; Tumwesigye E; Brantley J; Baeten JM; van Heerden A; Turyamureeba B; Joseph P; Krows M; Thomas KK; Schaafsma TT; Hughes JP; Celum C Lancet HIV; 2016 May; 3(5):e212-20. PubMed ID: 27126488 [TBL] [Abstract][Full Text] [Related]
10. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis. Brown LB; Getahun M; Ayieko J; Kwarisiima D; Owaraganise A; Atukunda M; Olilo W; Clark T; Bukusi EA; Cohen CR; Kamya MR; Petersen ML; Charlebois ED; Havlir DV; Camlin CS PLoS One; 2019; 14(1):e0210126. PubMed ID: 30673744 [TBL] [Abstract][Full Text] [Related]
11. Universal HIV Testing and Treatment With Patient-Centered Care Improves ART Uptake and Viral Suppression Among Adults Reporting Hazardous Alcohol Use in Uganda and Kenya. Puryear SB; Ayieko J; Hahn JA; Mucunguzi A; Owaraganise A; Schwab J; Balzer LB; Kwarisiima D; Charlebois ED; Cohen CR; Bukusi EA; Petersen ML; Havlir DV; Kamya MR; Chamie G J Acquir Immune Defic Syndr; 2023 Sep; 94(1):37-45. PubMed ID: 37220015 [TBL] [Abstract][Full Text] [Related]
12. Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria. Ogoina D; Finomo F; Harry T; Inatimi O; Ebuenyi I; Tariladei WW; Afolayan AA PLoS One; 2015; 10(5):e0125665. PubMed ID: 25933356 [TBL] [Abstract][Full Text] [Related]
13. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda. Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P Glob Health Action; 2014; 7():21843. PubMed ID: 24433941 [TBL] [Abstract][Full Text] [Related]
14. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa. Havlir DV; Balzer LB; Charlebois ED; Clark TD; Kwarisiima D; Ayieko J; Kabami J; Sang N; Liegler T; Chamie G; Camlin CS; Jain V; Kadede K; Atukunda M; Ruel T; Shade SB; Ssemmondo E; Byonanebye DM; Mwangwa F; Owaraganise A; Olilo W; Black D; Snyman K; Burger R; Getahun M; Achando J; Awuonda B; Nakato H; Kironde J; Okiror S; Thirumurthy H; Koss C; Brown L; Marquez C; Schwab J; Lavoy G; Plenty A; Mugoma Wafula E; Omanya P; Chen YH; Rooney JF; Bacon M; van der Laan M; Cohen CR; Bukusi E; Kamya MR; Petersen M N Engl J Med; 2019 Jul; 381(3):219-229. PubMed ID: 31314966 [TBL] [Abstract][Full Text] [Related]
15. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Siegfried N; Uthman OA; Rutherford GW Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364 [TBL] [Abstract][Full Text] [Related]
16. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial. Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694 [TBL] [Abstract][Full Text] [Related]
17. Immunodeficiency at Antiretroviral Therapy Start: Five-Year Adult Data (2012-2017) Based on Evolving National Policies in Rural Mozambique. Arinze F; Gong W; Green AF; De Schacht C; Carlucci JG; Silva W; Claquin G; Tique JA; Stefanutto M; Graves E; Van Rompaey S; Alvim MFS; Tomo S; Moon TD; Wester CW AIDS Res Hum Retroviruses; 2020 Jan; 36(1):39-47. PubMed ID: 31359762 [TBL] [Abstract][Full Text] [Related]
18. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the SEARCH Studys. Shade SB; Osmand T; Luo A; Aine R; Assurah E; Mwebaza B; Mwai D; Owaraganise A; Mwangwa F; Ayieko J; Black D; Brown LB; Clark TD; Kwarisiima D; Thirumurthy H; Cohen CR; Bukusi EA; Charlebois ED; Balzer L; Kamya MR; Petersen ML; Havlir DV; Jain V AIDS; 2018 Sep; 32(15):2179-2188. PubMed ID: 30134294 [TBL] [Abstract][Full Text] [Related]
19. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study. Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L; PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181 [TBL] [Abstract][Full Text] [Related]
20. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya. Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]